David Carbone, MD, PhD, a survivor of lymphoma and director, James Thoracic Center, The Ohio State University Comprehensive Cancer - The James, discusses pain management in the context of being a patient and a physician.
David Carbone, MD, PhD, a survivor of lymphoma and director, James Thoracic Center, The Ohio State University Comprehensive Cancer — The James, discusses pain management in the context of being a patient and a physician.
Survival Benefit, Durable Responses Continue at 3 Years With Liso-cel in Second-line LBCL
July 15th 2024Three-year findings from the TRANSFORM trial provide further evidence that liso-cel should be considered as the new standard of care along with other CAR T-cell therapies for patients with primary refractory or relapsed LBCL, an expert said.